Cargando…
Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes
Autores principales: | Watchorn, David, O’Shea, Donal, Butler, Marcus W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017582/ https://www.ncbi.nlm.nih.gov/pubmed/33508209 http://dx.doi.org/10.1164/rccm.202011-4162LE |
Ejemplares similares
-
Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes
por: Foer, Dinah, et al.
Publicado: (2021) -
Weight Loss in Individuals with Obesity and Asthma
por: Watchorn, David, et al.
Publicado: (2019) -
Asthma Exacerbations and Glucagon-Like Peptide-1 Receptor Agonists: a Review of the Current Evidence
por: Kaplan, Alan G., et al.
Publicado: (2022) -
Glucagon-like Peptide-1 Receptor Agonists and the Risk of Acute Kidney Injury: Alarming, or Not?
por: Patoulias, Dimitrios, et al.
Publicado: (2021) -
In Reply to ‘Glucagon-like Peptide-1 Receptor Agonists and the Risk of Acute Kidney Injury: Alarming, or Not?’
por: Leehey, David J.
Publicado: (2021)